Healthcare -
Biotechnology - NASDAQ - US
$ 8.32
2.4 %
$ 316 M
Market Cap
14.0
P/E
TRDA - TOTAL CURRENT LIABILITIES
Total Current Liabilities TRDA - Entrada Therapeutics, Inc.
39.5 M
LAST VALUE
34.05%
2 YEAR CAGR
83.05%
5 YEAR CAGR
0.00%
10 YEAR CAGR